COLGATE PALMOLIVE CO（CL）の決算・業績分析
COLGATE PALMOLIVE COの2025年有価証券報告書をAI分析。売上高$20.4B(+1.4%)。営業利益$3.3B。Materials。
目次
COLGATE PALMOLIVE COの2025年度 業績サマリー
COLGATE PALMOLIVE CO（証券コード: CL）の2025年度決算・業績分析。売上高は$20.4B（前年比+1.4%）。営業利益は$3.3B（前年比-22.5%）。純利益は$2.1B（前年比-26.2%）。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。
COLGATE PALMOLIVE COの2024年度 注目ポイント
※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。
- Revenue grew 3.1% YoY to $18.0B (XBRL), but operating income fell 13.2% YoY to $2.9B (XBRL) due to increased costs from geopolitical conflicts and supply chain challenges (10-K).
- Net income declined 17.6% YoY to $1.8B (XBRL), despite strong gross margins of 57.0% (XBRL) and a record ROE of 293.1% (XBRL).
- Shareholder returns totaled $3.0B (XBRL) through dividends ($1.7B) and buybacks ($1.3B), despite net debt of $7.3B (2.1x EBITDA) (XBRL).
COLGATE PALMOLIVE COの売上高変化の要因
- •Total revenue reached $18.0B in FY2024, reflecting a 3.1% YoY increase (XBRL). Growth was driven by geographic diversification (two-thirds of revenue from outside the U.S.) and focus on core segments (10-K). However, segment-specific revenue figures are not disclosed in XBRL data or 10-K text (N/A). The 5-year revenue CAGR of 4.6% (XBRL) contrasts with a 17.6% YoY decline in net income (XBRL), highlighting margin compression from rising costs (10-K).
COLGATE PALMOLIVE COの営業利益変化の要因
- •Gross profit of $10.2B (XBRL) maintained a strong 57.0% margin (XBRL), but operating income fell 13.2% YoY to $2.9B (XBRL) due to increased costs from the Ukraine war and supply chain disruptions (10-K). Net income declined 17.6% YoY to $1.8B (XBRL), with operating margin at 16.1% (XBRL) and net margin at 9.9% (XBRL). The 5-year operating income CAGR of 1.5% (XBRL) and net income CAGR of -0.8% (XBRL) indicate long-term margin pressures.
COLGATE PALMOLIVE COの事業リスクと対応
International operations face risks from foreign currency fluctuations, political instability, and trade policy changes (10-K).
Geopolitical tensions (e.g., Ukraine, Middle East) disrupt supply chains, increase costs, and affect cash repatriation (10-K).
Macroeconomic volatility (inflation, recession) harms profitability and operational efficiency (10-K).
Regulatory/legal risks include trade restrictions, tariffs, and unstable legal systems in certain countries (10-K).
Environmental/social risks (pandemics, labor unrest) disrupt operations and consumer demand (10-K).
COLGATE PALMOLIVE COの今後の見通し・業績予想
COLGATE PALMOLIVE COの事業内容
Colgate-Palmolive Co (CL) operates as a global consumer goods company, generating revenue through the sale of Oral, Personal & Home Care, and Pet Nutrition products (10-K). The company's revenue model relies on brand leadership in key categories like toothpaste (Colgate, Darlie) and liquid hand soap (Palmolive), supported by a 57.0% gross margin (XBRL). Key segments include Oral, Personal & Home Care (43% of FY2024 net sales), Pet Nutrition (22%), and other categories (18% and 17%) (XBRL). Competitive advantages include a strong global brand portfolio, operational efficiency (ROE: 293.1% (XBRL)), and a sustainability strategy (10-K). Walmart, Inc. and its affiliates accounted for 11% of FY2024 net sales, with no other customer exceeding 10% (10-K).
COLGATE PALMOLIVE COのAI業績分析レポート（2024年度）
Colgate-Palmolive Co (CL) FY2024 Annual Report Analysis
Highlights
Business Overview
Colgate-Palmolive Co operates as a global consumer goods company, generating revenue through Oral, Personal & Home Care, and Pet Nutrition products (10-K). Key segments include Oral, Personal & Home Care (43% of FY2024 net sales), Pet Nutrition (22%), and other categories (18% and 17%) (XBRL). Competitive advantages include brand leadership (e.g., Colgate toothpaste), operational efficiency (ROE: 293.1% (XBRL)), and a sustainability strategy (10-K). Walmart, Inc. and its affiliates accounted for 11% of FY2024 net sales, with no other customer exceeding 10% (10-K).
Revenue Analysis
Total revenue reached $18.0B in FY2024, reflecting a 3.1% YoY increase (XBRL). Growth was driven by geographic diversification (two-thirds of revenue from outside the U.S.) and focus on core segments (10-K). However, segment-specific revenue figures are not disclosed in XBRL data or 10-K text (N/A). The 5-year revenue CAGR of 4.6% (XBRL) contrasts with a 17.6% YoY decline in net income (XBRL), highlighting margin compression from rising costs (10-K).
Profitability Analysis
Gross profit of $10.2B (XBRL) maintained a strong 57.0% margin (XBRL), but operating income fell 13.2% YoY to $2.9B (XBRL) due to increased costs from the Ukraine war and supply chain disruptions (10-K). Net income declined 17.6% YoY to $1.8B (XBRL), with operating margin at 16.1% (XBRL) and net margin at 9.9% (XBRL). The 5-year operating income CAGR of 1.5% (XBRL) and net income CAGR of -0.8% (XBRL) indicate long-term margin pressures.
Balance Sheet Analysis
The company reported a 3.7% equity ratio (XBRL) and a high D/E ratio of 25.35x (XBRL), with $8.2B in long-term debt (XBRL) and $7.3B in net debt (2.1x EBITDA) (XBRL). Liquidity stood at $966M in cash (XBRL), but the current ratio of 1.11x (XBRL) suggests limited short-term asset coverage. Total assets grew to $16.4B in FY2024 (XBRL), while total equity fell to $609M (XBRL) in FY2024 from $743M in FY2021 (XBRL).
Cash Flow Analysis
Operating cash flow of $2.6B (XBRL) outpaced net income of $1.8B (XBRL), driven by a 43-day cash conversion cycle (CCC) (XBRL). Free cash flow (FCF) totaled $955M (XBRL), but investing cash flow was -$1.6B (XBRL) and financing cash flow was -$952M (XBRL). Shareholders received $3.0B in returns via dividends ($1.7B) and buybacks ($1.3B) (XBRL).
Working Capital Analysis
The CCC was 43 days (XBRL), with receivables days at 32, inventory days at 92, and payables days at 80 (XBRL). Asset turnover of 1.10x (XBRL) indicates moderate efficiency in converting assets to revenue.
Risks
Outlook
Management guidance is not explicitly provided in the 10-K (truncated). Historical FY2025 revenue projection is $19.5B (XBRL), but forward-looking trends highlight ongoing challenges from the Ukraine war (costs, supply chains) and geographic diversification (10-K).
Materialsの企業一覧
COLGATE PALMOLIVE COと同じ「Materials」セクターの企業